Anemia Management in Pediatric Chronic Kidney Disease: Current Challenges and Treatment Strategies

Altaf Jamil1, Barbara Gruner1, Javairia Jamil2

  • 1Department of Pediatrics, Division of Hematology and Oncology, University of Missouri School of Medicine, Columbia, MO USA.

Insights

Iron deficiency anemia (IDA) is common in pediatric chronic kidney disease (CKD) but often overlooked. Effective management with iron and erythropoiesis-stimulating agents (ESAs) improves outcomes, though diagnosis and treatment targets remain challenging.

Area of Science:

  • Nephrology
  • Pediatrics
  • Hematology

Background:

  • Iron deficiency anemia (IDA) is a frequent complication in pediatric chronic kidney disease (CKD).
  • Anemia in pediatric CKD is linked to reduced quality of life and increased morbidity/mortality.
  • Causes include low erythropoietin (EPO) production, iron deficiency, and inflammation (high hepcidin).

Purpose of the Study:

  • To review the complexities of managing anemia in pediatric CKD.
  • To highlight the role of iron supplementation and ESAs in treatment.
  • To discuss challenges in diagnosis and setting treatment goals.

Main Methods:

  • Literature review on anemia in pediatric CKD.
  • Analysis of iron supplementation and ESA efficacy.
  • Discussion of diagnostic and therapeutic challenges.

Main Results:

  • Intravenous (IV) iron effectively treats iron-restricted erythropoiesis and improves ESA response.
  • Anemia management in pediatric CKD is complex due to multiple factors.
  • Accurate diagnosis and target setting for anemia in this population are ongoing challenges.

Conclusions:

  • Iron supplementation and ESAs are crucial for managing anemia in pediatric CKD.
  • Addressing iron deficiency is key to optimizing erythropoiesis and patient outcomes.
  • Further research is needed to refine diagnostic criteria and treatment targets for anemia in pediatric CKD.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
231
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
37
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
50
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
56
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
35